Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Stuart Kendrick

Newcastle AuthorsTitleYearFull text
Dr Vinod Hegade
Dr Stuart Kendrick
Professor David Jones
Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus2019
Dr Vinod Hegade
Dr Holly Fisher
Dr Stuart Kendrick
Professor David Jones
Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom2019
Dr Jess Dyson
Dr Lin Lee Wong
Dr Theophile Bigirumurame
Dr Stuart Kendrick
Professor David Jones
et al.
Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom2018
Dr Vinod Hegade
Dr Stuart Kendrick
Professor David Jones
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study2017
Dr Vinod Hegade
Dr Stuart Kendrick
Professor David Jones
A Phase 2 Randomised Crossover Trial of Ileal Bile Acid Transporter Inhibitor GSK2330672 in Patients with Primary Biliary Cholangitis and Symptoms of Pruritus2016
Dr Vinod Hegade
Dr Stuart Kendrick
Professor David Jones
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial2016
Dr Lin Lee Wong
Dr Stuart Kendrick
Professor David Jones
Dr Jess Dyson
UK-AIH - Highlighting the need for standardization of treatment in autoimmune hepatitis2016
Dr Jess Dyson
Dr Jeremy Palmer
Dr Lin Lee Wong
Dr Stuart Kendrick
Professor David Jones
et al.
Understanding the importance of pro- and anti-inflammatory cytokines in autoimmune hepatitis2016
Dr Lin Lee Wong
Dr Stuart Kendrick
Dr Jess Dyson
Professor David Jones
Understanding the unmet need in Autoimmune Hepatitis - The United Kingdom AIH Study (UK-AIH)2016
Dr Vinod Hegade
Dr Stuart Kendrick
Professor David Jones
A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of repeat doses of GSK2330672 administration in subjects with primary biliary cirrhosis and symptoms of pruritus2015
12